Cross-institutional, multifaceted, integrated translational research on hepatocellular carcinoma to develop prevention and treatment strategies, including meta-analyses, cost-effectiveness evaluations, and assessments of healthcare inequities
Funding Agency
Ministry of Health and Welfare
Principal Investigator
Chun-Ying Wu
Project Period
2026/01/01～2029/12/31
National Science and Technology Council
Project Title
Predicting Prognosis of MASLD-related HCC Treatment: Building an Automated System Integrating Clinical Data, Imaging, and Environmental Factors
Investigating the Interplay between Diabetes and Inflammatory Skin Diseases
Funding Agency
National Science and Technology Council
Principal Investigator
Chen-Yi Wu
Project Period
2025/08/01～2028/07/31
Industry-Academia Collaboration
Project Title
Cell-based Drug Screening Trial Evaluation
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2023/05/01～2024/08/31
Project Title
Mouse Animal Model Drug Trial Evaluation Project
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2023/05/01～2024/01/31
Project Title
Comprehensive HBV Drug Trial Evaluation Project
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2024/04/01～2025/03/31
Project Title
[Handa Biopharmaceutical Co., Ltd.] Evaluating the Efficacy and Safety of Dasatinib in the Treatment of Chronic Phase Chronic Myeloid Leukemia Patients: A Real-World Study Conducted in Taiwan
